𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neoadjuvant cisplatin and interferonα-2b (IFNα-2b) with 13-cis retinoic acid (13-cRA) in bulky squamous cell carcinoma of the cervix stage IB and IIA

✍ Scribed by W. Termrunguanglert; D. Tresukosol; T. Sittisomwong; A. Vasuratna; R. Lerkhachonsuk; P. Worasethsin; S. Triratanachat; S. Niruthisard; N. Sirisabya


Book ID
117125857
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
164 KB
Volume
70
Category
Article
ISSN
0020-7292

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Combination of alpha-interferon 2a (α-IF
✍ S. Toma; M. Airoldi; R. Palumbo; P. Raffo; C. Bumma 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 53 KB 👁 1 views

It is well known that survival of patients with advanced squamous-cell carcinoma of the head and neck (SCCHN) has not significantly improved despite recent advances in radiation and chemotherapy treatment. Specifically, a very low objective response rate can be obtained in patients with recurrent SC

Phase II clinical trial of 13-cis-retino
✍ Peter C. Enzinger; David H. Ilson; Leonard B. Saltz; Lisa K. Martin; David P. Ke 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

## BACKGROUND. Interferon in combination with 5-fluorouracil has been shown to be active in squamous cell carcinoma (SCC) and adenocarcinoma (AC) of the esophagus. 13-cis-retinoic acid (CRA) has chemopreventive activity in SCC of the head and neck, and, in combination with interferon, has antitumo

Induction of cell cycle arrest and apopt
✍ Xin Zhang; Zhuo (Georgia) Chen; Fadlo R. Khuri; Dong M. Shin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB

## Abstract ## Background. We have previously conducted phase II trials with a combination of 13‐__cis__‐retinoic acid (13‐cRA), interferon‐α2a (IFN‐α2a), and α‐tocopherol (α‐TF) in patients with advanced oral premalignant lesions and locally advanced head and neck cancer in the adjuvant settings